Your browser doesn't support javascript.
loading
Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids.
Qian, Xi; Yanagi, Karin; Kane, Anne V; Alden, Nicholas; Lei, Ming; Snydman, David R; Vickers, Richard J; Lee, Kyongbum; Thorpe, Cheleste M.
Afiliação
  • Qian X; Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts.
  • Yanagi K; Department of Chemical and Biological Engineering, Tufts University, Medford, Massachusetts.
  • Kane AV; Tufts Medical Center, Boston, Massachusetts.
  • Alden N; Department of Chemical and Biological Engineering, Tufts University, Medford, Massachusetts.
  • Lei M; Department of Chemical and Biological Engineering, Tufts University, Medford, Massachusetts.
  • Snydman DR; Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts.
  • Vickers RJ; Tufts Medical Center, Boston, Massachusetts.
  • Lee K; Tufts University School of Medicine, Boston, Massachusetts.
  • Thorpe CM; Summit Therapeutics, Plc, Abingdon, United Kingdom.
Am J Physiol Gastrointest Liver Physiol ; 319(2): G227-G237, 2020 08 01.
Article em En | MEDLINE | ID: mdl-32597706
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Benzimidazóis / Ácidos e Sais Biliares / Clostridiales / Microbioma Gastrointestinal / Antibacterianos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Benzimidazóis / Ácidos e Sais Biliares / Clostridiales / Microbioma Gastrointestinal / Antibacterianos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article